(Q40670369)
Statements
The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells (English)
Francesca Brugnolo
Salvatore Sampognaro
Francesco Liotta
Lorenzo Cosmi
Cinzia Manuelli
Paolo Campi
Enrico Maggi
Sergio Romagnani
Paola Parronchi